Safety and efficacy of abciximab in older adults undergoing percutaneous coronary intervention
ConclusionAbciximab may not be associated with excess bleeding complications in older patients compared with younger individuals and may be safe to use in older people if indicated.
Source: International Journal of Clinical Practice - Category: Internal Medicine Authors: R. A. Brown, E. Shantsila, C. Varma, G. Y. H. Lip Tags: Original Paper Source Type: research
More News: Abciximab | Angioplasty | Bleeding | Cardiology | Cardiovascular | Coronary Angioplasty | Databases & Libraries | Heart | Internal Medicine | Percutaneous Coronary Intervention | Study